⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22130437 | 0.81 | — | — | |
| SCHEMBL4488533 | 0.81 | — | — | |
| SCHEMBL30845814 | 0.80 | — | — | |
| SCHEMBL3173360 | 0.80 | IDO1 (0.31) | — | |
| SCHEMBL14118008 | 0.80 | AHR (0.41) | — | |
| SCHEMBL4502073 | 0.77 | TDP1 (0.31) | — | |
| SCHEMBL4502733 | 0.75 | — | — | |
| SCHEMBL6948341 | 0.75 | — | — | |
| SCHEMBL4148188 | 0.74 | — | — | |
| SCHEMBL4150127 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022094174-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ESOPHAGEAL CONDITIONS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2022-05-05 | — | — | WO | claimed |
| US-20210060158-A1 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2021-03-04 | — | — | US | claimed |
| EP-3684410-A1 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | Institut Curie (FR) | 2020-07-29 | — | — | EP | claimed |
| WO-2019115576-A1 | METHODS OF TREATING HEART FAILURE | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2019-06-20 | — | — | WO | claimed |
| WO-2019057744-A1 | AGONIST OF ARYL HYDROCARBON RECEPTOR FOR USE IN CANCER COMBINATION THERAPY | INSTITUT CURIE (FR) | 2019-03-28 | — | — | WO | claimed |
| US-20180256617-A1 | METHODS FOR EXTENDING LIFESPAN AND METHODS OF SCREENING KNOWN PHARMACOLOGICAL AGENTS FOR NEW USES | LONGEVICA THERAPEUTICS INC. | 2018-09-13 | — | — | US | claimed |
| US-20160343960-A1 | Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-11-24 | — | — | US | claimed |
| WO-2016168670-A2 | METHODS FOR EXTENDING LIFESPAN AND METHODS OF SCREENING KNOWN PHARMACOLOGICAL AGENTS FOR NEW USES | LONGEVICA THERAPEUTICS INC. (US) | 2016-10-20 | — | — | WO | claimed |
| EP-1030663-B1 | TREATMENT OF FIBROMYALGIA AND RELATED DISORDERS | DESIGNED NUTRITIONAL PRODUCTS (US) | 2010-03-10 | — | — | EP | claimed |
| EP-1030663-A4 | TREATMENT OF FIBROMYALGIA AND RELATED DISORDERS | DESIGNED NUTRITIONAL PRODUCTS (US) | 2002-06-26 | — | — | EP | claimed |
| EP-1030663-A1 | TREATMENT OF FIBROMYALGIA AND RELATED DISORDERS | Designed Nutritional Products Inc. (US) | 2000-08-30 | — | — | EP | claimed |
| WO-1999017768-A1 | TREATMENT OF FIBROMYALGIA AND RELATED DISORDERS | DESIGNED NUTRITIONAL PRODUCTS, INC. (US) | 1999-04-15 | — | — | WO | claimed |
| US-20260091097-A1 | COMBINATION TREATMENT REGIMES FOR TREATING CANCER | BARINTHUS BIOTHERAPEUTICS NORTH AMERICA INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-12497385-B2 | Photoprotective compositions containing Malassezia-derived compounds and/or chemical analogs thereof | VERSICOLOR TECHNOLOGIES, LLC (US) | 2025-12-16 | — | — | US | disclosed |
| EP-3522902-B1 | PROBIOTIC BACTERIA PRODUCING AN AHR AGONIST AND THEIR USE IN THE TREATMENT OF METABOLIC SYNDROME AND OBESITY | INSTITUT NATIONAL DE RECH POUR LAGRICULTURE LALIMENTATION ET LENVIRONNEMENT (FR) | 2025-09-03 | — | — | EP | disclosed |
| EP-4608455-A1 | SELF-ASSEMBLING NANOPARTICLES | Barinthus Biotherapeutics North America, Inc. (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-1030663-A1 | TREATMENT OF FIBROMYALGIA AND RELATED DISORDERS | Designed Nutritional Products Inc. (US) | 2000-08-30 | — | — | EP | disclosed |
| US-6001868-A | ADMINISTERING TO AN INDIVIDUAL AN EFFECTIVE AMOUNT OF AN INDOLE-3-CARBINOL COMPOUND OR A DERIVATIVE TO TREAT TUMOR CELL GROWTH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-12-14 | — | — | US | disclosed |
| US-5895787-A | Treatment of fibromyalgia and related disorders | DESIGNED NUTRITIONAL PRODUCTS, INC. (US) | 1999-04-20 | — | — | US | disclosed |
| WO-1999017768-A1 | TREATMENT OF FIBROMYALGIA AND RELATED DISORDERS | DESIGNED NUTRITIONAL PRODUCTS, INC. (US) | 1999-04-15 | — | — | WO | disclosed |